Comparison of Formulas for Calculating Low-Density Lipoprotein Cholesterol in General Population and High-Risk Patients with Cardiovascular Disease

被引:23
|
作者
Choi, Hansol [1 ,3 ]
Shim, Jee-Seon [3 ]
Lee, Myung Ha [2 ,3 ]
Yoon, Young Mi [3 ]
Choi, Dong Phil [3 ]
Kim, Hyeon Chang [2 ,3 ]
机构
[1] Yonsei Univ, Grad Sch, Dept Publ Hlth, Seoul, South Korea
[2] Yonsei Univ, Coll Med, Dept Prevent Med, 50-1 Yonsei Ro, Seoul 03722, South Korea
[3] Yonsei Univ, Coll Med, Cardiovasc & Metab Dis Etiol Res Ctr, Seoul, South Korea
关键词
Low-density lipoprotein cholesterol; Cholesterol; Triglyceride; Friedewald formula; DIRECT HOMOGENEOUS ASSAY; LDL-CHOLESTEROL; FRIEDEWALD FORMULA; DIABETES-MELLITUS; MANAGEMENT; REGRESSION; EQUATIONS; VALUES;
D O I
10.4070/kcj.2016.46.5.688
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and Objectives: Low-density lipoprotein cholesterol (LDL-C), an established cardiovascular risk factor, can be generally determined by calculation from total cholesterol, high-density lipoprotein cholesterol, and triglyceride concentrations. The aim of this study was to compare LDL-C estimations using various formulas with directly measured LDL-C in a community-based group and hospital-based group among the Korean population. Subjects and Methods: A total of 1498 participants were classified into four groups according to triglyceride concentrations as follows: <100, 100-199, 200-299, and >= 300 mg/dL. LDL-C was calculated using the Friedewald, Chen, Vujovic, Hattori, de Cordova, and Anandaraja formulas and directly measured using a homogenous enzymatic method. Pearson's correlation coefficients, intraclass correlation coefficients (ICC), Passing & Bablok regression, and Bland-Altman plots were used to evaluate the performance of six formulas. Results: The Friedewald formula had the highest accuracy (ICC=0.977; 95% confidence interval 0.974-0.979) of all the triglyceride ranges, while the Vujovic formula had the highest accuracy (ICC=0.876; 98.75% confidence interval 0.668-0.951) in people with triglycerides >= 300 mg/dL. The mean difference was the lowest for the Friedewald formula (0.5 mg/dL) and the percentage error was the lowest for the Vujovic formula (30.2%). However, underestimation of the LDL-C formulas increased with triglyceride concentrations. Conclusion: The accuracy of the LDL-C formulas varied considerably with differences in triglyceride concentrations. The Friedewald formula outperformed other formulas for estimating LDL-C against a direct measurement and the Vujovic formula was suitable for hypertriglyceridemic samples; it could be used as an alternative cost-effective tool to measure LDL-C when the direct measurement cannot be afforded.
引用
收藏
页码:688 / 698
页数:11
相关论文
共 50 条
  • [1] Low-density lipoprotein cholesterol and metabolic syndrome in an Iranian high-risk population
    Janghorbani, Mohsen
    Amini, Masoud
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2015, 9 (02) : 91 - 97
  • [2] The Relationship Between Low-Density Lipoprotein Cholesterol Levels and the Incidence of Cardiovascular Disease in High-Risk Patients Treated With Pravastatin
    Daida, Hiroyuki
    Teramoto, Tamio
    Kitagawa, Yasuhisa
    Matsushita, Yasuyuki
    Sugihara, Masahiro
    INTERNATIONAL HEART JOURNAL, 2014, 55 (01) : 39 - 47
  • [3] LOW-DENSITY LIPOPROTEIN CHOLESTEROL REDUCTION IN PATIENTS AT VERY HIGH CARDIOVASCULAR RISK
    Cherubini, A.
    Tollardo, M.
    Palcic, S.
    Scagnetto, A.
    Russo, G.
    Capelletto, C.
    Bollini, M.
    Di Lenarda, A.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2023, 25
  • [4] Strategies to achieve low-density lipoprotein cholesterol targets in high-risk patients
    Mantsiou, Chrysanthi
    Tziomalos, Konstantinos
    CURRENT MEDICAL RESEARCH AND OPINION, 2018, 34 (10) : 1713 - 1715
  • [5] Low-Density Lipoprotein Cholesterol, Cardiovascular Disease Risk, and Mortality in China
    Chen, Liang
    Chen, Shi
    Bai, Xueke
    Su, Mingming
    He, Linkang
    Li, Guangyu
    He, Guangda
    Yang, Yang
    Zhang, Xiaoyan
    Cui, Jianlan
    Xu, Wei
    Song, Lijuan
    Yang, Hao
    He, Wenyan
    Zhang, Yan
    Li, Xi
    Hu, Shengshou
    JAMA NETWORK OPEN, 2024, 7 (07)
  • [6] Metabolic syndrome, low-density lipoprotein cholesterol, and risk of cardiovascular disease: a population based study
    Jeppesen, J.
    Hansen, T.
    Rasmussen, S.
    Ibsen, H.
    Torp-Pedersen, C.
    EUROPEAN HEART JOURNAL, 2005, 26 : 445 - 445
  • [7] Cardiovascular Risk Beyond Low-Density Lipoprotein Cholesterol
    Mayr, Manuel
    Gerszten, Robert
    Kiechl, Stefan
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (06) : 633 - 635
  • [8] Variability in Low-Density Lipoprotein Cholesterol and Cardiovascular Risk
    Baber, Usman
    Halperin, Jonathan L.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (15) : 1549 - 1551
  • [9] Low-Density Lipoprotein Cholesterol, Non-High-Density Lipoprotein Cholesterol, Triglycerides, and Apolipoprotein B and Cardiovascular Risk in Patients With Manifest Arterial Disease
    van den Berg, M. Johanneke
    van der Graaf, Yolanda
    de Borst, Gert Jan
    Kappelle, L. Jaap
    Nathoe, Hendrik M.
    Visseren, Frank L. J.
    AMERICAN JOURNAL OF CARDIOLOGY, 2016, 118 (06): : 804 - 810
  • [10] Low-density lipoprotein cholesterol goal attainment in high-risk family medicine patients
    Griend, Joseph P. Vande
    Saseen, Joseph J.
    JOURNAL OF CLINICAL LIPIDOLOGY, 2009, 3 (03) : 195 - 200